Rimm DL - Search Results

1

Tissue microarray: a new technology for amplification of tissue resources.

Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, Reiss M. Rimm DL, et al. Cancer J. 2001 Jan-Feb;7(1):24-31. Cancer J. 2001. PMID: 11269645 Review.

2

The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.

Schofield K, D'Aquila T, Rimm DL. Schofield K, et al. Among authors: rimm dl. Cancer. 1997 Oct 25;81(5):293-8. Cancer. 1997. PMID: 9349517

3

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

4

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

5

A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 2000 Jan 1;88(1):108-13. Cancer. 2000. PMID: 10618612

6

Molecular biology in cytopathology: current applications and future directions.

Rimm DL. Rimm DL. Cancer. 2000 Feb 25;90(1):1-9. doi: 10.1002/(sici)1097-0142(20000225)90:1<1::aid-cncr1>3.0.co;2-c. Cancer. 2000. PMID: 10692210 Review.

7

The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.

Dillon DA, Johnson CC, Topazian MD, Tallini G, Rimm DL, Costa JC. Dillon DA, et al. Among authors: rimm dl. Cancer J. 2000 Sep-Oct;6(5):294-301. Cancer J. 2000. PMID: 11079168

8

Validation of tissue microarray technology in breast carcinoma.

Camp RL, Charette LA, Rimm DL. Camp RL, et al. Among authors: rimm dl. Lab Invest. 2000 Dec;80(12):1943-9. doi: 10.1038/labinvest.3780204. Lab Invest. 2000. PMID: 11140706 Free article.

9

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. Garcia-Rostan G, et al. Among authors: rimm dl. Am J Pathol. 2001 Mar;158(3):987-96. doi: 10.1016/s0002-9440(10)64045-x. Am J Pathol. 2001. PMID: 11238046 Free PMC article.

10

Amplification of tissue by construction of tissue microarrays.

Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Rimm DL, et al. Exp Mol Pathol. 2001 Jun;70(3):255-64. doi: 10.1006/exmp.2001.2363. Exp Mol Pathol. 2001. PMID: 11418004 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters